3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Venous Thromboembolism
1
Neoplasms
1
Embolism
1
Interventions
apixaban
3
edoxaban
1
abelacimab
1
Rosuvastatin Calcium
1
Rivaroxaban
1
N(4)-oleylcytosine arabinoside
1
MAA868
1
Heparin, Low-Molecular-Weight
1
Dalteparin
1
Dabigatran
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Venous Thromboembolism
×
edoxaban
×
90 days
×
Clear all
NCT04618913
2026-05-26
VICTORIE
Pfizer
Active not recruiting
1 enrolled